A Chronic Contact Eczema Impedes Migration of Antigen-Presenting Cells in Alopecia Areata
Alopecia Areata
T-Lymphocytes
Antigen-Presenting Cells
Dermatology
Dermatitis, Contact
Biochemistry
Mice
03 medical and health sciences
Cell Movement
Leukocytes
Animals
Molecular Biology
Skin
Mice, Inbred C3H
0303 health sciences
Cell Biology
3. Good health
Gene Expression Regulation
Chronic Disease
Female
Receptors, Chemokine
Lymph Nodes
Chemokines
Cell Adhesion Molecules
Hair Follicle
Cyclobutanes
Dendritic Cells, Follicular
DOI:
10.1038/sj.jid.5700328
Publication Date:
2006-05-04T17:41:53Z
AUTHORS (8)
ABSTRACT
Long-lasting allergen treatment is the most efficient therapy in alopecia areata (AA). The underlying mechanism is unknown. We here asked whether treatment with a contact sensitizer influences leukocyte migration such that dendritic cell (DC) migration or the recruitment of activated T-cells towards the skin become hampered. Allergen treatment of AA mice was not accompanied by a decrease in skin-infiltrating leukocytes or draining lymph node cells (LNC). However, the distribution of leukocyte subsets was changed with a dominance of monocytes in the skin and a reduced percentage of DCs in draining nodes. Chemokine and chemokine receptor expression in skin and draining nodes was strikingly increased and LNC from untreated and allergen-treated AA mice showed high migratory activity in vitro and readily homed in draining nodes and skin after intravenous injection. However, FITC labelling of the skin and subcutaneous transfer of dye-labelled DC revealed that allergen treatment created a chemokine milieu severely hampering DC migration from the skin towards the draining node. An allergic eczema-induced reduction in DC migration and antigen transfer could well contribute to insufficient T-cell activation and the recovery of hair follicle in AA and possibly be of relevance for other skin-related autoimmune diseases.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (57)
CITATIONS (17)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....